Monday, March 2nd-3.7°C
25405
23715

Given Imaging wins US approval for pill camera in patients who have trouble with colonoscopy

WASHINGTON - Given Imaging Ltd. said Monday it has won U.S. approval for an ingestible pill camera that can help doctors screen the large intestine for polyps and other early signs of colon cancer.

The Israeli company's technology, developed from missile defence systems, uses a battery-powered camera to take high-speed photos of the intestinal tract over the course of eight hours. The images are transmitted to a recording device worn around the patient's waist and later reviewed by a doctor.

Analysts originally expected Given's approach to directly compete with traditional colonoscopy procedures. But company studies found that the images taken by the mini-camera are not quite as clear as those of from the in-office procedure. As a result, the company has pursued a more limited market for its PillCam: patients who have trouble undergoing standard colonoscopies.

The Food and Drug Administration approved the company's PillCam Colon for patients who have experienced an incomplete colonoscopy. The company estimates 750,000 U.S. patients are not able to complete the procedure each year, due to anatomy issues, previous surgery or various colon diseases.

Even with this limited indication, analysts estimate the new pillcam could grow to sales of over $60 million in North America by 2019, with room for expansion as the technology improves. MorningStar analyst Debbie Wang said the company has shrewdly positioned the device as another tool in the gastrointestinal specialist's tool kit, rather than a direct competitor.

"Given's management understands that that traditional colonoscopy is the gastroenterologist's bread and butter right now," Wang said. "So they didn't want to do anything that would position this as a substitute." Wang points out that Given's PillCam costs $500, significantly less than the $4,000 for a colonoscopy. Eventually, she thinks doctors may use the device to attract adults who avoid regular screenings due to fears of pain, embarrassment and general discomfort. The Centers for Disease Control and Prevention's guidelines currently recommend regular colonoscopies beginning at age 50 and continuing until age 75, though the majority of American adults don't follow the recommendations.

In December, Irish medical device firm Covidien announced it would buy Given for about $860 million. Given, headquartered in Yoqneam, Israel, markets seven lines of medical devices and surgical supplies, including pillcams to screen the esophagus and small intestine.

Pillcam Colon was previously approved in 80 other countries, including in Japan, Europe and Latin America.

The Canadian Press


Read more Business News




Recent Trending




Today's Market
S&P TSX15264.05+29.71
S&P CDNX704.30-2.43
DJIA18288.63+155.93
Nasdaq5008.096+44.568
S&P 5002117.39+12.89
CDN Dollar0.7990+0.0014
Gold1220.40+7.80
Oil51.59-0.55
Lumber298.40-1.10
Natural Gas2.699-0.035

 
Okanagan Companies
Pacific Safety0.135+0.015
Knighthawk0.010.00
QHR Technologies Inc1.60+0.05
Cantex0.035-0.005
Anavex Life Sciences0.18-0.01
Metalex Ventures0.045+0.01
Russel Metals25.54+0.16
Copper Mountain Mining1.29-0.01
Colorado Resources0.135-0.015
ReliaBrand Inc0.008-0.0007
Sunrise Resources Ltd0.045-0.005
Mission Ready Services0.225-0.01

 



25103

FEATURED Property
1872290471 Swan Drive, Kelowna, BC
4 bedrooms 4 baths
$639,000
more details
image2image2image2
Click here to feature your property
Please wait... loading


Refinance your mortgage?

Canadian Mortgage rates are low and could be dropping down in time for the spring market following a drop in the Bank of Canada Rate on January 21 by 1/4% which will save new buyers and those with mo...


Creating your retirement vision

A vision means different things to different people. To the head of a large corporation, it’s the ability to chart a course that will deliver success (think Steve Jobs and Apple), to a shaman, i...


Are you asking the right questions?

Have you ever had this happen to you? You are in the middle of your second or third good discussion with a prospect and everything seems to be going great. The prospect seems engaged and happy to work...

_








Member of BC Press Council


24681